Glucocorticoid metabolism in the cardiac interstitium: 11 beta-hydroxysteroid dehydrogenase activity in cardiac fibroblasts
- PMID: 8340703
Glucocorticoid metabolism in the cardiac interstitium: 11 beta-hydroxysteroid dehydrogenase activity in cardiac fibroblasts
Abstract
The interstitial fibrosis seen in the heart and systemic organs in states of primary or secondary mineralocorticoid excess suggests that fibroblasts are responsive to mineralocorticoid. In vitro studies demonstrating increased fibroblast collagen synthesis in response to MC are consonant with this view. The nicotinamide-adenine dinucleotide phosphate(+)-dependent enzyme 11 beta-hydroxysteroid dehydrogenase converts the glucocorticoids corticosterone and cortisol to the inactive metabolites 11-dehydrocorticosterone and cortisone, respectively, conferring mineralocorticoid specificity to the cells within which it is active. We investigated the presence of 11 beta-hydroxysteroid dehydrogenase in sonicates of cultured vascular endothelial cells and cardiac fibroblasts by incubating sonicates for 1 hour in the presence of 5 x 10(-9) mol/L tritiated corticosterone or tritiated cortisol (1 microCi) and using reverse-phase high-performance liquid chromatography coupled to an on-line radioisotope detector for steroid separation and quantitation. Extracts of bovine endothelial cells showed no enzymatic activity with either substrate, whereas extracts of rat cardiac fibroblasts readily converted corticosterone to 11-dehydrocorticosterone, even in the absence of exogenous nicotinamide-adenine dinucleotide phosphate+ (10% conversion). When 5 x 10(-4) mol/L nicotinamide-adenine dinucleotide phosphate+ was added to sonicated fibroblasts, conversion increased to 50%, corresponding to 12 pmol 11-dehydrocorticosterone formed/mg protein. Conversion of cortisol to cortisone was not observed in fibroblast or endothelial cell extracts. Significant levels of corticosterone to 11-dehydrocorticosterone conversion (0.14 pmol/10(6) cells/hour) were detected in intact fibroblasts, but no 11-dehydrogenation of corticosterone was observed in intact endothelial cells.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Species diversity of 11 beta-hydroxysteroid dehydrogenase in the cardiovascular system.J Lab Clin Med. 1994 Dec;124(6):821-6. J Lab Clin Med. 1994. PMID: 7798796
-
11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.Endocrinology. 1991 Dec;129(6):3305-12. doi: 10.1210/endo-129-6-3305. Endocrinology. 1991. PMID: 1954906
-
High affinity NAD(+)-dependent 11 beta-hydroxysteroid dehydrogenase in the human heart.J Mol Cell Cardiol. 1996 Apr;28(4):781-7. doi: 10.1006/jmcc.1996.0072. J Mol Cell Cardiol. 1996. PMID: 8732505
-
11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?Front Neuroendocrinol. 1997 Jan;18(1):49-99. doi: 10.1006/frne.1996.0143. Front Neuroendocrinol. 1997. PMID: 9000459 Review.
-
Renal 11-beta-hydroxysteroid dehydrogenase: a mechanism ensuring mineralocorticoid specificity.Horm Res. 1990;34(3-4):114-7. doi: 10.1159/000181808. Horm Res. 1990. PMID: 1966561 Review.
Cited by
-
Vascular remodeling and mineralocorticoids.J Endocrinol Invest. 1995 Jul-Aug;18(7):533-9. doi: 10.1007/BF03349764. J Endocrinol Invest. 1995. PMID: 9221271 Review.
-
Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts.Mol Cell Biochem. 1996 Jan 26;154(2):171-8. doi: 10.1007/BF00226785. Mol Cell Biochem. 1996. PMID: 8717431
-
Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation.Mol Cell Biochem. 1998 Dec;189(1-2):47-54. doi: 10.1023/a:1006844010371. Mol Cell Biochem. 1998. PMID: 9879653